A correlation study of CEUS quantitative analysis and the expression of P53 in hepatocellular carcinoma
1.Department of Medical Ultrasonics, the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning 530023, China; 2.The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
Abstract:Objective: To investigate the expression of mutant P53 protein and their correlation with contrast-enhanced ultrasound quantitative parameters in hepatocellular carcinoma(HCC). Methods: Fifty-seven cases of HCC were enrolled. A retrospective analysis of the contrast-enhanced ultrasound quantitative parameters was performed, and then their correlation with P53 protein by immunohistochemistry staining method was done. Results:①P53 positive expression rate was 54.3%(31/57). ②In P53 positive and negative groups, the peak strength, the mean transit time and time to peak showed no significant difference(P>0.05). There was significant difference in the rising slope and washout time(P<0.05). ③There was no correlation between the expression of P53 and maximum intensity, mean transit time or time to peak(P>0.05). The positive expression of P53 was positively correlated with the rising slope with r=0.377(P<0.05), and negatively correlated with washout time with r=-0.410(P<0.05). Conclusion: For HCC contrast-enhanced ultrasound parameters, there is a certain correlation between rising slope, washout time and mutant P53 protein expression. The time-intensity curve might noninvasively assess the expression of P53.
马 振1,杨 红2,何 云2,卢景宁2,彭金波2,吴玉泉2. 肝细胞性肝癌超声造影定量分析与P53表达相关性研究[J]. 中国临床医学影像杂志, 2016, 27(1): 25-28.
MA Zhen1, YANG Hong2, HE Yun2, LU Jing-ning2, PENG Jin-bo2, WU Yu-quan2. A correlation study of CEUS quantitative analysis and the expression of P53 in hepatocellular carcinoma. JOURNAL OF CHINA MEDICAL IMAGING, 2016, 27(1): 25-28.
[1]Jemal A, Center MM, Ward E, et al. Cancer occurrence[J]. Cancer Epidemiol, 2009, 471(1): 3-29.
[2]Shariff MI, Jane C, Gomaa AI, et al. Hepatocellular carcinoma:current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics[J]. Expert Rev Gastroenterol Hepatol, 2014, 4(4): 19-37.
[3]Gartd AL, Radhakfishnan SK. Lost in transcription: p2l repression mechanisms, and consequences[J]. Cancer Res, 2005, 65(10): 3980-3985.
[4]Toegel S, Hoffmann O, Wadsak W. Uptake of bone-seekers issolely associated with mineralization A study with 99mTc-MDP, 153Sm EDTMP and 18F-fluoride on osteoblasts[J]. Eur J Nucl Med Mol Imaging, 2006, 33(4): 491-494.
[5]Patard JJ, Rioux-Leclercq N, Masson D, et al. Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma[J]. Br J Cancer, 2009, 101(8): 1417-1424.
[6]Burns PN, Wilson SR. Focal Liver Masses: Enhancement Patterns on Contrast-enhanced Images—Concordance of US Scans with CT Scans and MR Images[J]. Radiology, 2007, 242(1): 162-174.
[7]刘广健,吕明德,谢晓燕,等. 肝细胞性肝癌超声造影表现与肿瘤病理分化关系的研究[J]. 中国超声医学杂志,2006,22(3):209-212.
[8]霍英杰,袁静,杨景震,等. 3.0T MRI在肝癌随访中检出新发微小癌灶的影像研究[J]. 中国临床医学影像杂志,2014,25(2):98-102.
[9]李振洲,罗长锐,方凡,等. 乳腺癌超声造影定性及定量分析与p53表达的相关性研究[J]. 中国临床医学影像杂志,2012,23(7):465-467.
[10]Pei XQ, Liu LZ, Liu M, et al. Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and histological grading[J]. Br J Radiol, 2012, 85(1017): 740-747.
[11]拉孜,官泳松,次白. 血清P53抗体与原发性肝癌病理分化程度的相关性研究[J]. 西部医学,2011,23(1):93-95.